ProCE Banner Activity

A Positive Look Ahead: New Directions in Individualizing ART

Clinical Thought

The landscape of antiretroviral therapy is ever evolving. Read my commentary on how I think current investigational agents and future strategies may improve options for individualizing therapy and enhance satisfaction and treatment outcomes for persons living with HIV.

Released: August 09, 2023

Share

Faculty

Tristan J. Barber

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through an Independent Medical Education grant from Merck Sharp & Dohme LLC, Rahway, NJ, USA.

Merck Sharp & Dohme LLC, Rahway, NJ, USA

Disclosure

Primary Author

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Tristan J. Barber, MA, MD, FRCP: consultant/advisor/speaker: Gilead, Janssen, Merck Sharpe & Dohme, ViiV/GlaxoSmithKline.